- Analysts mostly lauded Accenture PLC's ACN Q4 results and FY22 outlook, slightly cautioned by the Q4 revenue miss.
- Related Content: Accenture Clocks 24% Revenue Growth In Q4, Hikes Dividend, Adds $3B Share Buyback
- Piper Sandler analyst Arvind Ramnani bumped the PT to $354 from $302, suggesting a 3.2% upside, and kept a Neutral rating.
- Citi analyst Ashwin Shirvaikar raised the PT to $390 from $340, implying a 13.7% upside, and reiterated a Buy.
- Morgan Stanley analyst James Faucette lifted the PT to $400 from $380, indicating a 16.6% upside, and maintained an Overweight.
- Argus analyst Jim Kelleher raised the PT to $400 from $330 and affirmed a Buy.
- Price Action: ACN shares traded lower by 0.23% at $342.32 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
